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Abstract 
Quality of life (QoL) is an increasingly important outcome measure in medicine. Health, in fact, is not only based on functional status but 
also on psychological and social well being. Since QoL is related to the patient’s perception of their position in life in relation to their 
goals, expectations, standards and concerns, the way in which the medical context is experienced may be critical. We then hypothesised 
that self-perceived QoL may be linked to unmet needs in information management and decision involvement. To analyse this hypothesis, 
we conducted a quantitative study on 84 consecutive patients with a diagnosis of primary high-grade glioma. The functional assessment 
of cancer therapy-Brain (FACT-Br) scales, the hospital anxiety and depression (HAD) scale and the need evaluation questionnaire (NEQ) 
questionnaire were used, in order to measure quality-of-life dimension, mood and unmet needs. Patients were classified as having no 
need (cluster 1), a moderate need (cluster 2) or a high need (cluster 3) to be more involved in the clinical process. 
Our data confirmed previous studies in other clinical areas, showing that shared decision might contribute to a better adaptation process 
to the illness [1]. In fact, patients in cluster 1 showed a significant better self-perceived QoL, despite the lack of clinical differences 
between clusters. The study showed that patients satisfied with respect to decisional involvement seem to be able to better cope with 
their disease. Finally, the study suggests the need for a more attuned decision-making process in approaching clinical decisions. 
Physicians need to better understand patient preferences related to information and decision sharing. 
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Introduction 
Brain cancers contribute to about 2% of the cancer mortality in 
men and 1.4% of the mortality in women, and within the age 
group 15–34 years, they are the third most common cause of 
death due to cancer. The most common types of brain tumours 
are glioblastoma multiforme (39% of all brain tumours), a high-
grade (grade IV) astrocytic tumour that is almost always 
debilitating and rapidly fatal (6% survive 2 years) and 
anaplastyc astrocytoma (grade III). Despite recent advances in 
diagnosis only modest improvements in survival are evident. 
However, the number of therapeutic options is increasing, and 
the importance of quality of life (QoL) is now well stated. In the 
last 10 years, several studies have investigated QoL issues in 
brain cancers. In particular, it has been shown that is possible to 
sustain a good QoL even though the prognosis remains poor. 
This may be due to the higher tolerability of treatments, but also 
to the specific attention that medical equips now give to QoL 
issues [2]. In particular, depression, anxiety and, generally 
speaking, emotional wellbeing are now common clinical targets. 
However, the available data are not always in agreement. Some 
studies, in fact, showed that most patients have pathological 
levels of depression, while others say the opposite [3–5]. 
Furthermore, it is not clear which patient characteristics may be 
important in influencing QoL. Some studies highlighted the role 
of the lesion site, functional status, physical symptoms, social 
support, coping strategies and gender [6–10]. However, the 
data do not seem to be conclusive. Furthermore, few 
researchers have investigated the relationship between QoL 
and the patient/physician relationship. In particular, specific 
needs  concerning information and decision sharing are poorly 
investigated in the domain of brain cancer QoL. In fact, QoL is a 
multidimensional concept that may be defined as the state of 
wellbeing that is a composite of two components: the ability to 
perform everyday activities that reflect physical, psychological 
and social well being and patient satisfaction with levels of 
functioning and control of the disease [11]. In this sense, we 
believe that the way patients experience the clinical setting may 
play a key role in the adjustment process to the illness and 
consequently in sustaining QoL. 
In the shared decision-making model, the power of control over 
the decision-making process is entirely entrusted to a patient.  
The interaction between patients, physicians and others (family 
members, for instance) is the starting point in the deliberation 
for the final decision making [12]. So, a patient has to be well 
informed on aetiology, symptoms, diagnostic methods, 
prognoses, advantages and eventual risks of different 
treatments in order to evaluate together with a physician the 
possible treatment alternatives in a conscientious and critical 
way. Thus, information is the crucial power for a patient, i.e., it is 
an essential condition for so-called empowerment. 
Consequently, the medical system should be able to be 
attentive to patient’s requirements and to satisfy their needs 
[13]. It means that physicians have to be able not only to 
provide patients with professionalism, respect for beliefs and 
convictions, but also have to meet their needs on being involved 
in the treatment details and therapeutic choices.  
Generally speaking, shared medical decision-making is 
supposed to be an ideal model to frame the patient/physician 
encounter [14]. Though the generalities of this method are 
largely accepted, the basic shared decision-making principles 
are not in reality always applied. Furthermore, the real 
preferences and needs of patients with regard to shared 
decisions are not systematically considered in clinical settings.  
Thus, the decision model to be applied depends often on the 
physician’s attitude and evaluations.  
The present study was aimed at evaluating objective indexes of 
health related quality of life in patients grouped by different 
shared decision needs. In particular, we wanted to verify the 
effect of unmet needs in this domain. In fact, we may 
hypothesise that the mismatch between the decision models 
used in the clinical setting, and the specific need of a patient to 
be involved may negatively contribute to self-perceived QoL. 
The need to have more information and/or to be more involved 
in medical decisions may interfere with the production of a 
context of trust and satisfaction with the therapeutic journey, 
holding back the adjustment process.   
 
Method 
Subjects 
109 consecutive patients were contacted. All the patients 
admitted were assessed for cognitive status. The first contact 
with the patient was carried out through the patient’s physician 
who was considered to be the reference person in determining 
the general condition of the patient. 10 patients were excluded 
for serious clinical conditions and 15 declined to participate.  
84 consecutive inpatients (mean age = 49.8, range = 26–65) 
with a histological diagnosis of malignant brain cancer (GBM or 
grade III Anaplastic Astrocytoma) agreed to take part in the 
study.  All the patients were diagnosed within the three months 
prior to participating in the study, and they were undergoing 
chemotherapy and/or radiotherapy.  
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Table 1: Patients’ characteristics 
Once the patient had been introduced by their physician, one 
specialized researcher explained the methods and purposes of 
the study. At this point, all privacy and ethical issues were 
raised, discussed and explained. A written form containing all 
the procedures, methods and contacts was given to the patient 
to take away, so as to give him/her the possibility to discuss 
potential participation also with proxies.  
During a second encounter, the patient was asked about their 
decision, if required further information was given at this point. A 
standard written informed consent was given to the patient and 
it’s content explained to the patient; if the patient agreed to 
participate he signed and returned the form. 
All contacted patients were aware that they had been operated 
on for a primitive cerebral neoplasm, and that they would need 
other therapies such as chemotherapy and radiotherapy to 
prevent recurrence. The patient’s physical and functional 
performance status were assessed through the Karnofsky 
performance status (KPS); the cognitive state was assessed by 
the mini-mental state examination (MMSE). To avoid any 
influence on patients QoL assessment, the interview was 
conducted by researchers not involved in the primary care. 
Follow-up visits were performed three months after the first 
session, to evaluate the QoL trend among patients with different 
needs. We chose to apply a second QoL evaluation after a 
short but salient period of time (three months), to test whether 
patients with different degrees of needs satisfaction developed 
different illness adjustment processes. In this period, the patient 
has had time to adjust to his/her new context following brain 
cancer diagnosis, and we could evaluate the impact of 
psychological variables on their QoL. A longer time interval may 
have allowed for physical deterioration, and so organizational 
factors could have interfered with our ability to test the 
hypothesis.  
The procedure used was in accordance with the ethical 
standard of the institutional committee on human 
experimentation.  
Patient characteristics are reported in the following Tables 1 
and 2. 
 
Instruments 
The Karnosky performance status scale 
The Karnosky performance status scale is a 100 point rating 
index widely used by physicians to assess patients’ physical 
and functional performance abilities. The value range was from 
0 (dead) to 100 (no impairment, normal activity).  
The mini-mental state examination 
This is a broadly used neuropsychological test used to briefly 
assess the cognitive status of patients. It is validated for Italian 
culture and corrected for age and education level. The value 
range was from 0 meaning the worst and 30 the best score. 
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Table 2: Clinical characteristics 
The hospital anxiety and depression scale 
The HADS is a self-administered question composed by two 
scales containing seven items, one for anxiety and one for 
depression, which should be used as two separate measures of 
emotional distress.   
The scale has been previously validated for Italian culture by 
Costantini and showed a high internal consistency with 
Crohnbach’s alpha ranging between 0.83 and 0.85 [15]. 
This scale evaluates symptoms of anxiety and depression 
avoiding misattribution due to physical aspects of the illness. 
The value range was from 0 to 21 for each scale. Cut-off scores 
were preliminary defined as: normal 0–5, light 6–8, moderate 9–
11 and heavy more than 11 either for the anxiety and 
depression patients [15]. 
The functional assessment of cancer therapy—brain  
The FACT-Br [16] is a self-administered questionnaire that 
measures the health-related quality of life. This instrument is 
mainly used for patients with chronic illnesses.  
It is composed by a core questionnaire called the Functional 
Assessment of Cancer Therapy General (FACT-G) and a 
specific subscale for brain.  
The FACT-G is composed of 27 items and has a five-point 
Likert scale (0–4). The higher scores correspond to better self-
perceived QOL. 
The FACT-G is divided in four domains: physical well being 
(seven items), social/family well being (seven items), emotional 
well being (six items) and functional wellbeing (seven items). 
The range of the score is 0–28 except emotional well being 
which is 0–24. A standardized score exists to transform raw 
data in a 0–100 scale, 100 corresponding to the best score. The 
specific brain cancer scale is composed by 19 further concerns 
items. Each item is based on the same five-point Likert scale 
and is specific for brain cancer problems. The score range is 0–
76. The sum of the four sub-scales of the core instrument and 
the specific brain scale give the FACT-Br total score is 0–184.  
Need evaluation questionnaire 
To evaluate patients’ needs, we used the NEQ [17]. This a 
questionnaire developed by Tamburini and colleagues [17] at 
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Table 3: Need evaluation questionnaire (NEQ). The table shows the first eight items of the NEQ, that is the information management session. 
the Cancer Institute of Milan. The questionnaire is made up of 
19 items, each one representing a specific need in an 
affirmative mode (e.g. ’I need  psychological support‘). The 
patient has to cross ‘yes’ or ‘no’.  
The first section (information management needs), made up of 
eight items, was considered in particular (see Table 3). 
 
Statistical analyses 
We classified patients for unmet needs with regard to decision 
sharing into three clusters (1, 2 and 3 involvement need).  In the 
first cluster, patients that presented complete satisfaction about 
decision and information management were included. This does 
not mean that patients in this cluster had higher needs 
regarding involvement in clinical decisions, simply that their 
needs were described as being met.  In the second cluster, 
patients were included who reported the need ‘to be more 
involved in therapeutic decisions’ (item 5 of the NEQ). Lastly, 
patients in the third cluster presented at least three unmet 
needs with regard to information sharing on the NEQ. 
To verify the hypothesis that unmet needs with regard to clinical 
decision involvement may affect patients QoL, we performed a 
series of analysis of variance (ANOVA), using QoL scores as 
dependent variables. All QoL scores were tested for normality 
with the Shapiro–Wilk test, showing p-values higher than 0.3 in 
all cases. Non-parametric tests were used when appropriate.  
All the statistical analyses were performed using the SPSS 
statistical software, version 17.0, and the results were 
considered statistically significant when the p-value was <0.05.  
Results 
Clusters composition is shown in Table 4. 
We compared these three clusters for gender, age, education, 
MMSE and KPS, to verify the homogeneity of clusters. The only 
significant difference was found in gender distribution among 
the three clusters (χ² = 6.135, p = 0.018). In fact, cluster 3 is 
clearly unbalanced since it includes many more men than 
women. No other effects were found, confirming the absence of 
significant clinical differences. 
The ANOVA test showed no significant difference between 
general QoL measures (FACT-G: F(2,83) = 0.579, p = 0.562; 
FACT-Br:  F(2,83) = 1.105; p = 0.379) between the three 
clusters considered. The Kruskal–Wallis non-parametric test 
also showed that the three clusters did not differ for depression 
(χ²  = 0.202, p = 0.911) or anxiety symptoms (χ² = 1.242, p = 
0.513).  
Since general scores comprised physical, social and 
psychological aspects, we carried out other ANOVA tests on the 
single FACT scales, using needs cluster as a fixed factor.  
The ANOVAs showed significant difference only for two sub-
scales: the emotional well being scale [F (2, 83) = 4.403, p 
=0.015, 1-β = 0.775] and the socio/familial scale [F(2, 83) = 
3.801, p = 0.028, 1-β = 0.812].  
Bonferroni post hoc analysis showed that patients in cluster 1 
reported significantly different values for socio/familial well being 
with respect to cluster 2 (mean difference = 9.65, p = 0.013) and 
cluster 3 (mean difference = 9.75, p = 0.014). Similarly, patients 
in cluster 1 reported different values in the emotional domain
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Table 4: Subjects characteristics distributions among needs clusters 
 
Table 5: Mean values and standard deviation for FACT sub-scales 
with respect to cluster 2 (mean difference = 8.78, p = 0.023) and 
to cluster 3 (mean difference = 8.15, p = 0.034).  As we can see 
from Table 5, patients in cluster 1 showed better emotional and 
socio/familial indexes (see Table 5).  
Since the subject distribution in the three clusters is unbalanced 
for gender, we performed further two way ANOVAs on QoL 
scores, using needs clusters as fixed factors and also gender as 
a fixed factor. The results showed that the needs cluster main 
effect were significant for emotional well-being [F(2, 83) = 3.94, 
p =0.023, 1-β = 0.755] as well as the interaction gender per 
cluster [F(2, 83) = 4.813, p = 0.010, 1-β= 0.810]. In particular, 
as shown in Table 6, women reported a higher value than men 
in cluster 3. No other effect was significant (p > 0.05 in all 
cases). 
Three months after the first assessment, we conducted a follow-
up session to evaluate the QoL trend among the three clusters. 
Eighty-one patients participated in the follow-up.  A mixed 
ANOVA, with needs (three levels) as between factor, and time 
(two levels) as within factor, was performed using FACT-Br as 
the dependent variable. No effect was found to be statistically 
significant (p >0 .10 in all cases). Since FACT-Br is a complex 
measure, we performed further ANOVA with needs (three 
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Table 6: Mean values and standard deviations of the FACT emotional well-being (EWB) scale 
levels) as between factor, and time (two levels) as within factor, 
using FACT sub-scales as dependent variables.  
The results indicated a significant interaction of needs and time 
for emotional [F (2, 80) = 11.312, p = 0.003, 1-β = 0.829] and 
social sub-scales [F(2,80) = 7.523, p = 0.011, 1-β= 0.788]. In 
particular, patients in clusters 2 and 3 showed a significant 
increase in both emotional and social well being, while patients 
in cluster 1 showed no particular differences.   
 
Conclusion 
A high-grade glioma is often a fatal diagnosis and the hope of 
living longer than five years overall for GBM, the most frequent 
histology, is poor. Although the patient is ‘terminal’ there are 
different therapeutic options which have been shown to be 
compatible with an acceptable quality of life [6]. Some studies 
have also addressed the possibility of further improving this 
situation through specific intervention (i.e. [18]). In this 
framework, it is vital to analyse all the conditions that may 
support psychological adjustment to this difficult journey. 
Different studies have shown the importance of treatment 
tolerability [8], symptoms relief [3], and psychological wellness 
[19, 20]. Furthermore, we know that subjective expectations are 
very important for the patient’s perception of their QoL [21, 22]. 
However, it is not clear how a patient builds their expectations 
and how they manage to fit the contextual demands of a severe 
diagnosis such as a brain cancer. Understanding unmet needs 
with regard to decisions involvement could represent a 
privileged way of understanding patients’ expectations.  In 
particular, our study underlines the importance of evaluating 
patients’ needs so as to attune the physicians’ behaviour with 
the patients’ requirement.  
Involving patients in decision making is becoming an important 
clinical task. However, it is essential to differentiate patients with 
regard to preferences and needs .We believe that a brief but 
systematic screening of patient characteristics is required in 
medical settings where important choices have to be made. 
The present research confirms previous studies in other clinical 
areas, showing that decision sharing might contribute to a better 
adaptation process to the illness [1].  
However, to our knowledge this is the first study that addresses 
the possible impact that an attuned decision model may have 
within the context of primary brain tumours. Our study strongly 
suggests the need for a more attuned decision-making process 
for approaching clinical decisions, even though aggressive 
therapies and a poor prognosis make it a difficult context for 
physicians and patients to discuss. The physician/patient 
encounter could be structured in order to meet reciprocal needs, 
improving compliance and satisfaction.  Our study suggests that 
within a similar encounter a shared decision model should be 
systematically applied. 
The present research has a number of methodological 
constraints that limit generalizations. The sample was relatively 
small, although comparable with other studies, as high-grade 
gliomas are a relatively infrequent pathology. Overall, most of 
our subjects had an acceptable KPS index, indicating the 
absence of particularly disabling symptoms and deficits. In 
patients with a KPS index lower than 70, or when symptoms are 
not well controlled by therapies (such as seizure), the QoL is 
strongly affected by physical conditions. Also psychological 
distress may contribute to a poor QoL, for instance in patients 
with a high level of anxiety or depression [23]. Our sample 
presented a low to moderate level of psychological distress, and 
this could limit the generalization of our data. However, since 
many patients with high-grade gliomas may live from some 
months to some years, with a substantially stable physical 
situation, we believe that it is important to identify how best to 
sustain the best QoL. In this framework, our study addressed 
the importance of considering the adequacy of information 
management and patient involvement. The study also 
addresses the need to provide physicians with standardized 
tools to evaluate this domain of the patient experience, often left 
to the qualitative assessment of the medical equipment. 
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